NCT07410364 Safety and Efficacy of CAG and PCI Via Distal Transradial Access in Patients With Small Vessels
| NCT ID | NCT07410364 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cai gaojun, MD |
| Condition | Coronary Artery Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 594 participants |
| Start Date | 2026-02-24 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 594 participants in total. It began in 2026-02-24 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized controlled trial of adaptive design for the safety and efficacy of coronary angiography and percutaneous coronary intervention via distal transradial access using a 6-French Glidesheath Slender in patients with small vessels.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 85 years * Palpable pulses in both the distal radial artery and conventional radial artery * All patients signed informed consent forms prior to procedure Exclusion Criteria: * Ultrasound assessment of the distal radial artery diameter ≥2.0mm or \<1.0mm * Height ≥185.0cm * Patients with acute ST-segment elevation myocardial infarction, cardiogenic shock, or hemodynamic instability * Contraindications for puncture of the distal radial artery * Patients with Raynaud's syndrome * Patients with coagulation disorders or hematologic diseases * Patients currently enrolled in other clinical studies
Contact & Investigator
haiyan HY zhang, BS
PRINCIPAL INVESTIGATOR
Wujin Hospital Affiliated with Jiangsu University.
Frequently Asked Questions
Who can join the NCT07410364 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07410364 currently recruiting?
Yes, NCT07410364 is actively recruiting participants. Contact the research team at caigaojun@wjrmyy.cn for enrollment information.
Where is the NCT07410364 trial being conducted?
This trial is being conducted at Changzhou, China, Changzhou, China.
Who is sponsoring the NCT07410364 clinical trial?
NCT07410364 is sponsored by Cai gaojun, MD. The principal investigator is haiyan HY zhang, BS at Wujin Hospital Affiliated with Jiangsu University.. The trial plans to enroll 594 participants.